Steviol Represses Glucose Metabolism and Translation Initiation in Pancreatic Cancer Cells

Sonam Kumari1, Mohammed Sikander1,2,3, Shabnam Malik1,2,3

  • 1Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN 38163, USA.

Biomedicines
|December 24, 2021
PubMed

Insights

Steviol, a natural compound, inhibits glucose metabolism and translation initiation in pancreatic cancer cells. This discovery offers potential for new combination therapies to combat aggressive pancreatic cancer.

Area of Science:

  • Biochemistry
  • Oncology
  • Molecular Biology

Background:

  • Pancreatic cancer exhibits the poorest prognosis and lowest survival rates among all cancers.
  • Pancreatic cancer cells display high metabolic activity, particularly aberrant glucose metabolism, leading to poor therapeutic response.
  • Understanding high glucose metabolism mechanisms is crucial for developing effective pancreatic cancer treatments.

Purpose of the Study:

  • To identify agents that can repress glucose metabolic machinery in pancreatic cancer cells.
  • To investigate the potential of steviol, a glycoside, in inhibiting pancreatic cancer cell metabolism and aggressiveness.
  • To explore steviol's impact on tumorigenic and metastatic potential.

Main Methods:

  • Assessed steviol's effect on glucose uptake and lactate production in pancreatic cancer cell lines (AsPC1 and HPAF-II).
  • Evaluated in vitro functional assays to determine the impact on cell growth, colonization, and invasion.
  • Analyzed steviol's effect on apoptosis, cell cycle arrest (G1/M phase), and key molecular targets including mTOR and translation initiation factors.

Main Results:

  • Steviol significantly inhibited glucose uptake and lactate production in pancreatic cancer cells.
  • Steviol treatment reduced pancreatic cancer cell growth, colonization, invasion, and metastatic potential.
  • Metabolic reprogramming by steviol involved the repression of mTOR and translation initiation proteins (4E-BP1, eIF4e, eIF4B, eIF4G), inducing apoptosis and G1/M cell cycle arrest.

Conclusions:

  • Steviol effectively suppresses glucose metabolism and translation initiation in pancreatic cancer cells, mitigating their aggressiveness.
  • The findings suggest steviol's potential as a therapeutic agent against pancreatic cancer.
  • This study may guide the development of novel combination therapeutic strategies for pancreatic cancer treatment.

Related Concept Videos

Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
14.2K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.5K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
4.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.2K
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.8K